ArticleInternational journal of molecular sciences2026
Exploring the Role of the LCN2-DHODH Interaction in Mitochondrial Ferroptosis During Sepsis-Induced Myocardial Injury and LPS-Induced HL-1 Cardiomyocyte Injury.
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
This study aimed to investigate the regulatory effect of lipocalin-2 (LCN2) knockdown on DHODH-mediated mitochondrial ferroptosis in sepsis-induced myocardial injury (SIMI) and clarify the underlying STAT3-related molecular mechanism in a cecal ligation and puncture (CLP) mouse model and lipopolysaccharide (LPS)-stimulated HL-1 cardiomyocyte injury model. We established a classic cecal ligation and puncture (CLP)-induced SIMI mouse model. Pharmacological suppression of ferroptosis was performed to confirm the pathogenic role of ferroptosis in SIMI progression. Subsequently, LCN2-knockdown mice were utilized to explore the biological function of LCN2 in modulating myocardial ferroptosis and septic cardiac injury, and the direct protein interaction between LCN2 and DHODH was verified via molecular docking and co-immunoprecipitation assays. In vitro, we constructed stable DHODH-overexpressing HL-1 cardiomyocytes via lentiviral transfection and established a lipopolysaccharide (LPS)-induced cardiomyocyte injury model. The results showed that LCN2 expression was markedly upregulated in SIMI. Both GPX4- and DHODH-dependent mitochondrial ferroptosis were significantly activated during SIMI. Lentivirus-mediated DHODH overexpression exerted prominent protective effects against LPS-induced cardiomyocyte injury. Importantly, pharmacological blockade of DHODH by Brequinar reversed the reduction of p-STAT3 induced by LCN2 silencing. However, Fin56-mediated specific inhibition of mitochondrial GPX4 exhibited no significant effect on STAT3 phosphorylation level, revealing distinct regulatory mechanisms for these two pathways. In summary, LCN2 knockdown inhibits DHODH-mediated mitochondrial ferroptosis to alleviate SIMI. Pharmacological inhibition of DHODH abrogates the cardioprotective effect of LCN2 knockdown by restoring STAT3 phosphorylation. These findings provide novel insights into the prevention and treatment of sepsis-induced myocardial injury.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.